How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,697 results for

Lymphedema

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

2. Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema (Full text)

Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema Breast cancer related lymphedema (BCRL) is a drastic situation that affects patients who have undergone breast cancer surgery. The impact of this condition on individuals' quality of life should be investigated in more detail to obtain better treatment results.In total, 65 patients with BCRL participated in this study. Nottingham Health Profile (NHP (...) ) was used to evaluate the validity of associated domains in Lymphedema Quality of Life Tool (LYMQoL). Both the LYMQoL and NHP were filled out by BCRL patients. To evaluate its test-retest reliability, the LYMQoL was subsequently performed seven days following its initial application. Measurement properties such as internal consistency, test-retest reliability, criterion validity and factor structure were tested. The internal consistency was assessed via Cronbach's alpha; test-retest reliability

2017 European journal of breast health PubMed

3. Intermittent Pneumatic Compression Devices for the Management of Lymphedema: A Review of Clinical Effectiveness and Guidelines

Intermittent Pneumatic Compression Devices for the Management of Lymphedema: A Review of Clinical Effectiveness and Guidelines Intermittent Pneumatic Compression Devices for the Management of Lymphedema: A Review of Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Intermittent Pneumatic Compression Devices for the Management of Lymphedema: A Review of Clinical Effectiveness and Guidelines Intermittent Pneumatic Compression Devices for the Management of Lymphedema (...) : A Review of Clinical Effectiveness and Guidelines Published on: May 12, 2017 Project Number: RC0881-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of intermittent pneumatic compression devices for patients with primary and secondary lymphedema? What is the comparative clinical effectiveness of single chamber intermittent pneumatic compression devices versus multi-chamber intermittent

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

4. Surgical treatment for lymphedema: a review of reviews

Surgical treatment for lymphedema: a review of reviews Surgical treatment for lymphedema: a review of reviews Surgical treatment for lymphedema: a review of reviews HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Surgical treatment for lymphedema: a review of reviews. Lansdale: HAYES, Inc. Directory Publication (...) . 2017 Authors' conclusions Lymphedema is the swelling of limbs caused by fluid accumulation, most commonly due to lymphatic injury caused by cancer treatment. Conservative management may confer insufficient control or be ineffective altogether, especially if lymphedema is advanced. Multiple surgical techniques have been developed with the intent of providing an effective lymphedema treatment option when conservative management fails. Rationale: Nonsurgical treatments are intensive and require

2017 Health Technology Assessment (HTA) Database.

5. Flexitouch system (Tactile Systems Technology Inc.) for lymphedema

Flexitouch system (Tactile Systems Technology Inc.) for lymphedema Flexitouch system (Tactile Systems Technology Inc.) for lymphedema Flexitouch system (Tactile Systems Technology Inc.) for lymphedema HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Flexitouch system (Tactile Systems Technology Inc.) for lymphedema. Lansdale: HAYES, Inc (...) . Healthcare Technology Brief Publication. 2017 Authors' conclusions The lymphatic system accepts fluid from the extracellular tissue and transports it into the cirulatory system. Lymphedema develops when this process is impaired, resulting in retention of fluid and proteins with consequent swelling and hardening in the tissue. Technology Description: The Flexitouch System is a programmable pneumatic compression device that is designed to increase transport of intersitial fluid from the periphery

2017 Health Technology Assessment (HTA) Database.

6. [Autologous lymph node transfer for lymphedema secondary to breast cancer]

[Autologous lymph node transfer for lymphedema secondary to breast cancer] [Autologous lymph node transfer for lymphedema secondary to breast cancer] [Autologous lymph node transfer for lymphedema secondary to breast cancer] Mengarelli C, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Mengarelli C, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A. [Autologous lymph node transfer for lymphedema secondary to breast cancer] Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Documentos de Evaluación de Tecnologías Sanitarias, Informe de Respuesta Rapida No 535. 2017 Authors' conclusions Very low-quality evidence suggests that lymph node transfer could decrease mastectomy-related upper-extremity

2017 Health Technology Assessment (HTA) Database.

7. Lymphedema

Lymphedema Lymphedema | ONS Hello [ Name ] ! Renew Membership: Hello [ Name ] ! Renew Membership: Menu Search Lymphedema is the accumulation of lymph fluid that obstructs the flow of the lymphatic system, causing persistent swelling of the affected body part. In the oncology setting, the most common causes of lymphedema are radiation therapy and lymph node dissection. Lymphedema can occur in one or more extremities and can involve the corresponding quadrant of the trunk. It can affect the head (...) and neck, breast, genitalia, and lower limbs, depending upon surgeries and radiation therapy performed; however, it is most often reported in the upper extremities of women with breast cancer associated with axillary lymph node dissection and fibrosis after radiation therapy. Upper-extremity lymphedema occurs in 15%–28% of breast cancer survivors, is most common in those who had axillary lymph node dissection, and can present a few days or six to eight weeks after surgery or radiation therapy. Lower

2017 Oncology Nursing Society Putting Evidence into Practice (PEP)

8. Validity of the Novel Taiwan Lymphoscintigraphy Staging and Correlation of Cheng Lymphedema Grading for Unilateral Extremity Lymphedema. (PubMed)

Validity of the Novel Taiwan Lymphoscintigraphy Staging and Correlation of Cheng Lymphedema Grading for Unilateral Extremity Lymphedema. The aim was to validate the new Taiwan Lymphoscintigraphy Staging, correlate it with Cheng Lymphedema Grading (CLG) and evaluate the treatment outcomes of unilateral extremity lymphedema.No consensus has been reached for diagnosis and staging for patients with lymphedema among medical specialties.We included 285 patients with unilateral extremity lymphedema (...) in the selection of the appropriate treatment to achieve favorable long-term outcomes in unilateral extremity lymphedema.

2018 Annals of Surgery

9. Blood Pressure Measurement as a Risk Factor for Lymphedema in Females Post Breast Cancer Treatment

Blood Pressure Measurement as a Risk Factor for Lymphedema in Females Post Breast Cancer Treatment "Blood Pressure Measurement as a Risk Factor for Lymphedema in Females " by Chelsea Braesch < > > > > > Title Author Date of Graduation Summer 8-10-2018 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies Rights . Abstract Background: Lymphedema is a common complication of breast cancer treatment. And while breast cancer survivors are at an increased risk (...) of developing lymphedema, there are various risk factors that, if avoided, might limit the incidence of arm swelling. A few national organizations have recommended that patients avoid blood pressure measurements on the affected arm. The purpose of this systematic review is to determine whether this burden is evidence-based or if it is causing unnecessary health anxiety. Methods: An exhaustive search of available medical literature was performed using MEDLINE-PubMed, Web of Science, and CINAHL. Key words

2018 Pacific University EBM Capstone Project

10. Donor-Site Lymphedema Following Lymph Node Transfer for Breast Cancer-Related Lymphedema: A Systematic Review of the Literature. (PubMed)

Donor-Site Lymphedema Following Lymph Node Transfer for Breast Cancer-Related Lymphedema: A Systematic Review of the Literature. Abstracts Background: Among current surgical options used for treating breast cancer-related lymphedema (BCRL), autologous lymph node transfer (ALNT) is shown to provide favorable results. However, postoperative donor-site lymphedema (DSL), following the lymphatic flap harvesting from the groin area, has already been reported. Our aim is to summarize the recent

2017 Lymphatic research and biology

11. Outcomes of Lymphedema Microsurgery for Breast Cancer-related Lymphedema With or Without Microvascular Breast Reconstruction. (PubMed)

Outcomes of Lymphedema Microsurgery for Breast Cancer-related Lymphedema With or Without Microvascular Breast Reconstruction. This study investigated the outcome of lymphedema microsurgery with or without microsurgical breast reconstruction for breast cancer-related lymphedema (BCRL).Complete decongestive therapy, lymphovenous anastomosis, and vascularized lymph node flap transfer are the 3 major treatment modalities for BCRL. Releasing axillary contracture and transferring a free flap may (...) potentially improve the BCRL.Between 2004 and 2015, 124 patients with BCRL who underwent 3 treatment modalities without or with microsurgical breast reconstruction were included in this study as groups I and II, respectively. Patients were offered the lymphedema microsurgery depending on the availability of patent lymphatic ducts on indocyanine green lymphography if they failed to complete decongestive therapy. The circumferential difference, reduction rate, and episodes of cellulitis were used

2017 Annals of Surgery

12. Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review. (Full text)

Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review. To identify the effect of decongestive lymphedema treatment on excess arm volume or patient-centered outcomes in women presenting within either 12 months or a mean nine months of developing arm lymphedema following breast cancer treatment.Lymphedema is a common consequence of breast cancer treatment requiring life (...) -long treatment to reduce symptoms and prevent complications. Currently, evidence to inform the optimal decongestive lymphedema treatment package is lacking.The review included studies on women who received lymphedema treatment within either 12 months or a mean of nine months of developing unilateral breast cancer-related arm lymphedema. The intervention was any decongestive lymphedema treatment delivered with the purpose of reducing arm lymphedema, compared to another form of lymphedema treatment

2018 JBI database of systematic reviews and implementation reports PubMed

13. Quantitative clinical outcomes of therapy for head and neck lymphedema (Full text)

Quantitative clinical outcomes of therapy for head and neck lymphedema Head and neck surgery and radiation cause tissue fibrosis that leads to functional limitations and lymphedema. The objective of this study was to determine whether lymphedema therapy after surgery and radiation for head and neck cancer decreases neck circumference, increases cervical range of motion, and improves pain scores.A retrospective review of all patients with squamous cell carcinoma of the oral cavity, oropharynx (...) , or larynx who were treated with high-dose radiation therapy at a single center between 2011 and 2012 was performed. Patients received definitive or postoperative radiation for squamous cell carcinoma of the oral cavity, oropharynx, or larynx. Patients were referred to a single, certified, lymphedema therapist with specialty training in head and neck cancer after completion of radiation treatment and healing of acute toxicity (typically 1-3 months). Patients underwent at least 3 months of manual

2018 Advances in radiation oncology PubMed

14. Machine learning for detection of lymphedema among breast cancer survivors (Full text)

Machine learning for detection of lymphedema among breast cancer survivors In the digital era when mHealth has emerged as an important venue for health care, the application of computer science, such as machine learning, has proven to be a powerful tool for health care in detecting or predicting various medical conditions by providing improved accuracy over conventional statistical or expert-based systems. Symptoms are often indicators for abnormal changes in body functioning due to illness (...) or side effects from medical treatment. Real-time symptom report refers to the report of symptoms that patients are experiencing at the time of reporting. The use of machine learning integrating real-time patient-centered symptom report and real-time clinical analytics to develop real-time precision prediction may improve early detection of lymphedema and long term clinical decision support for breast cancer survivors who face lifelong risk of lymphedema. Lymphedema, which is associated with more than

2018 mHealth PubMed

15. GJA4/Connexin 37 Mutations Correlate with Secondary Lymphedema Following Surgery in Breast Cancer Patients (Full text)

GJA4/Connexin 37 Mutations Correlate with Secondary Lymphedema Following Surgery in Breast Cancer Patients Lymphedema is a condition resulting from mutations in various genes essential for lymphatic development and function, which leads to obstruction of the lymphatic system. Secondary lymphedema is a progressive and incurable condition, most often manifesting after surgery for breast cancer. Although its causation appears complex, various lines of evidence indicate that genetic predisposition (...) may play a role. Previous studies show that mutations in connexin 47 are associated with secondary lymphedema. We have tested the hypothesis that connexin 37 gene mutations in humans are associated with secondary lymphedema following breast cancer surgery. A total of 2211 breast cancer patients were screened and tested for reference single nucleotide polymorphisms (SNPs) of the GJA4 gene (gap junction protein alpha 4 gene). The results presented in this paper indicate that two SNPs in the 3' UTR

2018 Biomedicines PubMed

16. Out-of-pocket payments, vertical equity and unmet medical needs in France: A national multicenter prospective study on lymphedema. (Full text)

Out-of-pocket payments, vertical equity and unmet medical needs in France: A national multicenter prospective study on lymphedema. Out-of-pocket payments might threaten the vertical equity of financing and generate unmet medical needs. The main objective was to assess the vertical equity of outpatient out-of-pocket payments for lymphedema patients in France. Twenty-seven centres, among which 11 secondary care hospitals and 16 primary care practices participated in this prospective national (...) multicenter study. We measured the lymphedema-specific outpatient out-of-pocket payments over 6 months. The vertical equity of out-of-pocket payments was examined using concentration curves, the Gini coefficient for income, the Kakwani index, and the Reynolds-Smolensky index. We included 231 lymphedema patients aged 7 years or more, living in metropolitan France, and being able to use Internet and email. After voluntary health insurance reimbursement, the mean out-of-pocket payment was equal to 101.4

2019 PLoS ONE PubMed

17. Manual lymphatic drainage for lymphedema following breast cancer treatment. (Full text)

Manual lymphatic drainage for lymphedema following breast cancer treatment. More than one in five patients who undergo treatment for breast cancer will develop breast cancer-related lymphedema (BCRL). BCRL can occur as a result of breast cancer surgery and/or radiation therapy. BCRL can negatively impact comfort, function, and quality of life (QoL). Manual lymphatic drainage (MLD), a type of hands-on therapy, is frequently used for BCRL and often as part of complex decongestive therapy (CDT (...) ), and Cochrane Breast Cancer Group's Specialised Register from root to 24 May 2013. No language restrictions were applied.We included randomized controlled trials (RCTs) or quasi-RCTs of women with BCRL. The intervention was MLD. The primary outcomes were (1) volumetric changes, (2) adverse events. Secondary outcomes were (1) function, (2) subjective sensations, (3) QoL, (4) cost of care.We collected data on three volumetric outcomes. (1) LE (lymphedema) volume was defined as the amount of excess fluid left

2015 Cochrane PubMed

18. [Postoperative administration of octreotide to reduce lymphorrhea, lymphocele, lymphedema and lymphatic ascites after lymphadenectomy in gynecological malignancies]. (PubMed)

[Postoperative administration of octreotide to reduce lymphorrhea, lymphocele, lymphedema and lymphatic ascites after lymphadenectomy in gynecological malignancies]. Octreotide is a synthetic analogue of natural somatostatin. Octreotide effect on lymphorrhea reduction in gynecological malignancies has only been assessed in case studies.Original work.Gynecologic Oncology Center, Department of Obstetrics and Gynecology, Faculty of Medicine, Masaryk University and University Hospital Brno.In 2014 (...) ), blood loss (p = 0.494). Nor lymphedema (p = 0.404), nor lymphocele (p = 0.086), correlated with postoperative lymphorrhea. Lymphatic ascites was associated with lymphorrhea (p = 0.048).Octreotide did not reduce lymphorrhea and the incidence of lymphocele, lymphedema of lower extremities and lymphatic ascites within one year of follow-up period after surgery. According to our results, we do not recommend to administer the octreotide in oncogynecological patients after pelvic and/or paraaortic

2017 Ceska gynekologie

19. Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA (Full text)

Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA The Oncology Section of APTA developed a clinical practice guideline to aid the clinician in diagnosing secondary upper-quadrant cancer-related lymphedema.Following a systematic review of published studies and a structured appraisal process, recommendations were written to guide the physical therapist and other health care clinicians in their diagnostic process. Overall (...) , clinical practice recommendations were formulated on the basis of the evidence for each diagnostic method and were assigned a grade based on the strength of the evidence for different patient presentations and clinical utility.In an effort to make these clinically applicable, recommendations were based on the characteristics as to the location and stage of a patient's upper-quadrant lymphedema.

2017 Rehabilitation oncology (American Physical Therapy Association. Oncology Section) PubMed

20. Taxane-based chemotherapy and risk of breast cancer-related lymphedema: protocol for a systematic review and meta-analysis

Taxane-based chemotherapy and risk of breast cancer-related lymphedema: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>